Best Biotech Catalyst Tools (2026)
The main tools for tracking biotech catalysts — FDA decisions, PDUFA dates and clinical-trial readouts — with what each is genuinely best for. Each comparison links to the tool's own site.
Disclosure: this list is published by CatalystAlert, so we're not a neutral third party. We've described each competitor from their own public site (verified 2026-05-31) and link out so you can judge for yourself.
CatalystAlert is a biotech catalyst intelligence platform tracking FDA decisions, PDUFA dates, and clinical-trial readouts for 1,600+ biotech stocks. Every catalyst date carries a confidence rating — confirmed against an official regulatory source, estimated, or AI-detected — alongside AI entry-timing and a public, scored prediction track record.
Best for: verifiable, confidence-labeled dates, AI entry-timing, and a public scored track record.
Pricing: Free tier (calendar, watchlist, weekly digest); Pro $29.99/mo (full calendar, AI predictions, alerts, smart-money); Elite $99.99/mo (API).
The long-standing biotech catalyst destination — a free FDA/PDUFA calendar plus a biotech company screener and database, widely used by retail biotech traders.
Best for: A free, established FDA/PDUFA calendar with the largest community.
Pricing: Free FDA calendar; paid premium tiers (incl. BPIQ). Confirm current pricing on their site.
A professional biotech & pharma pipeline-intelligence platform — ML probability-of-approval with confidence intervals, 10,000+ drugs, and 13F institutional tracking, positioned as a lower-cost Bloomberg/FactSet alternative.
Best for: Institutional-grade pipeline intelligence with 13F tracking.
Pricing: Paid, month-to-month, cancel anytime. Confirm current pricing on their site.
Pharma catalyst intelligence for swing traders — a 0–10 quantitative risk/reward score on every FDA decision, PDUFA date and Phase 2/3 readout, built from momentum, short interest, cash runway and event probability.
Best for: A single 0–10 swing-trade score on every catalyst.
Pricing: €19.99/mo, billed monthly, no tiers. Confirm current pricing on their site.
An AI-powered biotech catalyst tracker that adds automated portfolio generation and event alerts on top of an FDA catalyst calendar.
Best for: AI portfolio generation on top of a catalyst calendar.
Pricing: Around $29/mo for premium. Confirm current pricing on their site.
Plain-English AI clinical-trial analysis for retail investors — paste a ClinicalTrials.gov ID for a readable interpretation, plus a catalyst calendar and 600+ company profiles.
Best for: Plain-English interpretation of individual clinical trials.
Pricing: Free tier; premium around $19/mo (7-day trial). Confirm current pricing on their site.
FAQ
What is the best biotech catalyst tracker in 2026?
It depends on what you need. BioPharmCatalyst is the established free FDA/PDUFA calendar; BioMarkets.io offers institutional pipeline intelligence and 13F tracking; Biocat scores catalysts 0–10 for swing traders; BioCatalyst adds AI portfolio generation; ClinicalInvestor explains individual trials in plain English; and CatalystAlert focuses on verifiable, confidence-labeled dates, AI entry-timing, and a public, scored prediction track record.
Are there free biotech catalyst calendars?
Yes. BioPharmCatalyst, ClinicalInvestor and CatalystAlert all offer a free tier with a catalyst/FDA calendar; advanced predictions and alerts are typically paid.
How should I verify a catalyst date before trading it?
Always confirm a date against its official source — the FDA, the company’s SEC filings (EDGAR), or ClinicalTrials.gov. CatalystAlert labels each date as confirmed, estimated, or AI-detected so you know which need a second check.